Business
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
On Track to Deliver $13 Million of Oral TPOXX to an International Customer in Second QuarterExpect to Deliver $26 Million of IV TPOXX to the U.S. Government Strategic National Stockpile by End of the Third Quarter Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2026. “Consistent with our lon
About this update from Siga Technologies Inc.
[{"type":"image","alt":"SIGA Technologies Inc.","displaySize":"","headline":null,"caption":"SIGA Technologies Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":111,"url":"https://media.zenfs.com/en/globenewswire.com/76be374ea01bcb9ae606c39d2d18d285"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mbCyVmhNZdAdPUabejtBLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1NQ--/https://media.zenfs.com/en/globenewswire.com/76be374ea01bcb9ae606c39d2d18d285","width":300,"height":111},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/mbCyVmhNZdAdPUabejtBLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1NQ--/https://media.zenfs.com/en/globenewswire.com/76be374ea01bcb9ae606c39d2d18d285","width":300,"height":111}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"On Track to Deliver $13 Million of Oral TPOXX to an International Customer in Second Quarter","length":92,"tagName":"p"}]},{"val":[{"type":"text","content":"Expect to Deliver $26 Million of IV TPOXX to the U.S. Government Strategic National Stockpile by End of the Third Quarter ","length":121,"tagName":"p"}]},{"val":[{"type":"text","content":"Corporate Update Conference Call Today at 4:30 PM ET","length":52,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":265,"olType":false},{"type":"text","content":"NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2026.","length":208,"tagName":"p"},{"type":"text","content":"“Consistent with our long-term strategy, we expect to deliver more than $35 million of oral and IV TPOXX to a combination of the U.S. Government and an international customer across the second and third quarters of 2026," stated Diem Nguyen, Chief Executive Officer. "Our focus remains on securing new procurement contracts and orders that can drive our business going forward, building upon our long track record as a successful partner to the U.S. and international governments.”","length":491,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"9","style":"vertical-align:bottom;","val":[{"type":"text","content":"Summary Financial Results","length":25,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"9","style":"vertical-align:bottom;","val":[{"type":"text","...